Zoetis Inc. Announces Third Quarter and Nine Months Ended September 30, 2024 Results
Financial Highlights
- Third-quarter revenue was $2.2 billion, an increase of 8% compared to the prior-year period.
- Net income for the third quarter was $514 million, an increase of 12% compared to the prior-year period.
- Diluted earnings per share for the third quarter were $0.98, an increase of 13% compared to the prior-year period.
- Revenue for the nine months ended September 30, 2024 was $6.4 billion, an increase of 7% compared to the prior-year period.
- Net income for the nine months ended September 30, 2024 was $1.5 billion, an increase of 10% compared to the prior-year period.
- Diluted earnings per share for the nine months ended September 30, 2024 were $2.86, an increase of 11% compared to the prior-year period.
Business Highlights
- Companion animal segment revenue increased 8% in the third quarter and 7% for the nine months ended September 30, 2024, driven by strong demand for our core products and services.
- Livestock segment revenue increased 7% in the third quarter and 6% for the nine months ended September 30, 2024, driven by growth in our swine and poultry businesses.
- We continue to invest in our research and development pipeline, with a strong focus on innovation in areas such as precision medicine, digital health, and sustainability.
- We are committed to delivering long-term value to our shareholders, and we believe that our strong financial performance and business momentum position us well for continued growth in the future.
Outlook
We are pleased with our performance in the third quarter and the first nine months of 2024. We believe that we are well-positioned to continue to drive growth in the future. We remain focused on executing our strategy, investing in our business, and delivering value to our shareholders.
